BKYI vs EXAS · rev $4.1M vs rev $2.76B
BIO-Key International Inc (BKYI) versus EXACT Sciences Corporation (EXAS) — a side-by-side from cached financials, not a winner call.
BIO-Key International Inc (BKYI) is a security & protection services company listed on NASDAQ.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Latest reported BKYI revenue for 2026-06-30 was $4.1M. Net income was -$781.9K. Revenue was up 89.5% from 2026-03-31 to 2026-06-30. BKYI currently screens at market cap $4.2M.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
BKYI currently screens at market cap $4.2M. EXAS currently screens at market cap $20.03B.
Not investment advice. Open the BKYI and EXAS stock pages for the full models.
Not investment advice.